These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 115901)

  • 21. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
    Huang MC; Ashmun RA; Avery TL; Kuehl M; Blakley RL
    Cancer Res; 1986 May; 46(5):2362-8. PubMed ID: 2421877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.
    Mann GJ; Fox RM
    J Clin Invest; 1986 Nov; 78(5):1261-9. PubMed ID: 3490493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells.
    Griffig J; Koob R; Blakley RL
    Cancer Res; 1989 Dec; 49(24 Pt 1):6923-8. PubMed ID: 2573423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.
    Boss GR; Pilz RB
    J Clin Invest; 1984 Oct; 74(4):1262-8. PubMed ID: 6332827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
    Kinahan JJ; Otten M; Grindey GB
    Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.
    Mitchell BS; Mejias E; Daddona PE; Kelley WN
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5011-4. PubMed ID: 311004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of de novo pyrimidine nucleotide and DNA synthesis and growth of cultured Novikoff rat hepatoma cells and other cell lines by pyrazofurin (NSC 143095).
    Plagemann PG; Behrens M
    Cancer Res; 1976 Oct; 36(10):3807-12. PubMed ID: 182363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.
    Lin AL; Elford HL
    J Biol Chem; 1980 Sep; 255(18):8523-8. PubMed ID: 6997299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
    Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
    J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic and metabolic effects of adenosine and adenine on human lymphoblasts.
    Snyder FF; Hershfield MS; Seegmiller JE
    Cancer Res; 1978 Aug; 38(8):2357-62. PubMed ID: 667833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immune insufficiency in enzyme defects of purine metabolism].
    Müller G
    Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells.
    Matsumoto M; Weckbecker G; Cory JG
    Cancer Commun; 1990; 2(1):1-6. PubMed ID: 2369548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
    Mitchell BS; Kelley WN
    Ann Intern Med; 1980 Jun; 92(6):826-31. PubMed ID: 6247948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
    Thuillier L; Garreau F; Cartier PH
    Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes.
    Snyder FF; Mendelsohn J; Seegmiller JE
    J Clin Invest; 1976 Sep; 58(3):654-66. PubMed ID: 956393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
    Parker WB; Shaddix SC; Chang CH; White EL; Rose LM; Brockman RW; Shortnacy AT; Montgomery JA; Secrist JA; Bennett LL
    Cancer Res; 1991 May; 51(9):2386-94. PubMed ID: 1707752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.